A study using rats have lead scientists to develop a new drug that may partially relieve paralyzing spinal cord injuries.
Jerry Silver, Ph.D., professor of neurosciences, Case Western Reserve University School of Medicine, Cleveland, said that they are very excited at the possibility that millions of people could, one day, regain movements lost during spinal cord injuries.
Bell's Palsy
Bell''s palsy is facial nerve disorder that causes weakness of the muscles on one side of the face. Its cause is unknown but most people make a full recovery within 8 to 12 weeks.
Advertisement
On a hunch, Bradley Lang, Ph.D., the lead author of the study and a graduate student in Dr. Silver's lab, came up with the idea of designing a drug that would help axons regenerate without having to touch the healing spinal cord, as current treatments may require.
Dr. Lang and his colleagues designed a drug called ISP to block the enzyme and facilitate the drug's entry into the brain and spinal cord. Injections of the drug under the skin of paralyzed rats near the injury site partially restored axon growth and improved movements and bladder functions.
![Lucid Dreamers Help Scientists Locate the Seat of Meta-Consciousness in the Brain]( "Lucid Dreamers Help Scientists Locate the Seat of Meta-Consciousness in the Brain")
New studies on lucid dreaming have now helped scientists discover the seat of meta-consciousness of the brain.
Previous studies suggested their movements are blocked when the protein tyrosine phosphatase sigma (PTP sigma), an enzyme found in axons, interacts with chondroitin sulfate proteoglycans, a class of sugary proteins that fill the scars.
Drugs were designed to mimic the shape of a critical part of PTP sigma, called the wedge and different designs were tested on neurons grown in petri dishes alongside impenetrable barriers of proteoglycans. Treatment with ISP freed axon growth.
When the researchers looked at the spinal cords under a microscope they found that the drug induced sprouting of axons that use the neurochemical serotonin to communicate. The sprouting axons were seen below the injury site. Treating some rats with a blocker of serotonin communication partially reversed the beneficial effects of ISP injections, suggesting the newly sprouting axons helped the rats recover.
The study was published in the journal Nature.
Source: ANI
Lucid Dreamers Help Scientists Locate the Seat of Meta-Consciousness in the Brain
New studies on lucid dreaming have now helped scientists discover the seat of meta-consciousness of the brain.
Advertisement
Previous studies suggested their movements are blocked when the protein tyrosine phosphatase sigma (PTP sigma), an enzyme found in axons, interacts with chondroitin sulfate proteoglycans, a class of sugary proteins that fill the scars.
Drugs were designed to mimic the shape of a critical part of PTP sigma, called the wedge and different designs were tested on neurons grown in petri dishes alongside impenetrable barriers of proteoglycans. Treatment with ISP freed axon growth.
When the researchers looked at the spinal cords under a microscope they found that the drug induced sprouting of axons that use the neurochemical serotonin to communicate. The sprouting axons were seen below the injury site. Treating some rats with a blocker of serotonin communication partially reversed the beneficial effects of ISP injections, suggesting the newly sprouting axons helped the rats recover.
The study was published in the journal Nature.
Source: ANI
How to Deal with a Stroke
Stroke is a brain attack, which occurs when the blood supply to the brain is interrupted. It affects all age groups; according to the WHO, 15 million people are affected by stroke annually.
Advertisement
 Parkinsons DiseaseParkinson's disease is a neurodegenerative disease caused by progressive dopamine brain cells loss. Symptoms of Parkinson's disease are correctable to an extent. | Advertisement
|
Advertisement
Recommended Reading
Latest Research News
New study findings delineate how aging affects the immune response following Spinal cord injury (SCI) and highlight the participation of the spinal cord meninges in repair.
A recent clinical trial suggests that the first medication therapy to reduce the progression of nearsightedness in children could be on the way.
Autoimmune disorders were found to be linked to Sjogren's, systemic lupus erythematosus, and systemic sclerosis.
Successful brain pacemaker implantation has helped a 51year old Parkinson's disease patient to revitalize her quality of life.
Recent recommendations on lifestyle behaviors to prevent progression of rheumatic and musculoskeletal diseases revealed.